FDA authorizes Pfizer booster shots for seniors, high-risk people
The Food and Drug Administration on Wednesday authorized Pfizer booster shots for people above the age of 65 or who are at high risk.
In a press release sent to Fox Business, the FDA said it has approved a single booster shot for certain people to be administered at least six months after receiving their first two doses.
These groups include individuals 65 years and older, and individuals ages 18 to 64 who are either at "high risk of severe COVID-19" or who work in high-risk places.
"Today’s action demonstrates that science...